[ET Net News Agency, 6 August 2021] WUXI BIO (02269) fell 4.93% to HK$123.4, dipping
below the 50-D SMA of HK$128.922.
It hits an intra-day low of HK$123.2, and an intra-day high of HK$132. The total shares
traded was 7.69 million, with a value of HK$968.56m. The active buy/sell ratio is 49:51,
with net selling turnover of HK$9.19m. CHINA INNOVATION MARKET SER accounts for greatest
net responsive buying turnover of HK$27.66m, with volume weighted average price of
HK$126.132. UBS SEC accounts for greatest net responsive selling turnover of HK$117.78m,
with volume weighted average price of HK$125.636. The stock has fallen a combined 6.02%
over the past 2 consecutive trading days.
The Hang Seng Index now fell 19 points, or 0.07% to 26,185; the Hang Seng China
Enterprises Index now fell 20 points, or 0.22% to 9,275; the Hang Seng TECH Index now fell
12 points, or 0.19% to 6,702; with an overall turnover of HK$106.84b.
The SSE Composite Index now fell 24 points, or 0.71% to 3,441, with an overall turnover
of RMB424.57b.
The SZSE Component Index now fell 109 points, or 0.73% to 14,763, with an overall
turnover of RMB303.3b.
Basic Information
-------------------------------------------
Nominal 123.400 % Chg -4.93%
High 132.000 Low 123.200
Shares Tr 7.69m Turnover 968.56m
10-D SMA 121.890 %H.V 77.875
20-D SMA 128.800 VWAP 125.988
50-D SMA 128.922 RSI14 46.700
-------------------------------------------
Status: Dipping below the 50-D SMA, active buy/sell ratio is 49:51, with net selling
turnover of HK$9.19m, falling a combined 6.02% over the past 2 consecutive
trading days
Table: Performance of stocks in the same sector or of relevance
Stock (Code) Price(HK$) Change(%)
-------------------------------------------------
WUXI BIO (02269) 123.40 -4.93
HUTCHMED (00013) 67.80 +3.51
GENSCRIPT BIO (01548) 37.80 -1.56
INNOVENT BIO (01801) 73.95 -5.19
JXR (01951) 14.12 +0.28
BRII-B (02137) 27.75 +12.35
CANSINOBIO-B (06185) 369.40 -3.04
AKESO-B (09926) 46.45 -2.21
KINTOR PHARMA-B (09939) 72.65 -6.86
ALPHAMAB-B (09966) 20.90 -4.35
-------------------------------------------------
(ed)